Notice Information
Notice Title
Cardiovascular & Respiratory Medicines
Notice Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Information
Epoprostenol powder and solvent (pH12) for solution for infusion vials
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Epinephrine (Adrenaline) Auto Injector DevicesSupply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Urokinase InjectionsSupply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire
Isosorbide Mononitrate Modified Release Capsules and TabletsSupply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Diltiazem Hydrochloride Modified Release Capsules and TabletsSupply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Verapamil Hydrochloride Modified Release Capsules and TabletsSupply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Nifedipine Modified Release Capsules and TabletsSupply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Theophylline Modified Release Capsules and TabletsSupply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Branded and Branded Generic InhalersSupply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All Other Cardiovascular & Respiratory MedicinesSupply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was tendered as an individual Lot and awarded to a single framework participant.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire
Bosentan TabletsSupply of Bosentan Tablets to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Epoprostenol powder and solvent (pH10.5) for solution for infusion vialsSupply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Fondaparinux Sodium Pre-filled SyringesSupply of Fondaparinux Sodium Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Epinephrine (Adrenaline) InjectionsSupply of Epinephrine (Adrenaline) Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000577439
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360816
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £32,858,043 £10M-£100M
- Lots Value
- £32,571,777 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £15,912,988 £10M-£100M
Notice Dates
- Publication Date
- 16 Jul 20197 years ago
- Submission Deadline
- 30 Apr 2019Expired
- Future Notice Date
- Not specified
- Award Date
- 1 Jul 20197 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Unsuccessful
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Postcode Area
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR349301
Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360816
Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.